Craft

Advanced Oncotherapy

Advanced Oncotherapy Summary

Company Summary

Overview
Advanced Oncotherapy is a specialist developer and provider of the next generation of particle therapy systems that makes radiation less toxic for patients. Our aim is to create a bright future in cancer care with our advanced LIGHT technology. Vision: To develop a more affordable proton-based radiotherapy system, using an innovative and clinically more effective technology, and saving more cancer lives. Mission: To facilitate the wider use of radiation with protons for treating all forms of radio-sensitive cancers by commercialising a novel technology, and building on the success and scientific know-how of CERN (Centre Européen pour la Recherche Nucléaire).
Type
Private
Status
Active
Founded
1994
HQ
London, GB | view all locations
Website
https://www.avoplc.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Mike Sinclair

    Mike Sinclair, Executive Chairman

  • Nicolas Serandour

    Nicolas Serandour, Chief Executive Officer, DIrector

  • Ed Lee

    Ed Lee, Chief Operating Officer & President, Europe

  • Steve Myers

    Steve Myers, Executive Chairman, ADAM S.A

    LocationsView all

    6 locations detected

    • London, England HQ

      United Kingdom

      4 Tenterden St, Mayfair

    • Syracuse, NY

      United States

      120 Walton St #301

    • Den Haag, ZH

      Netherlands

      Kazernestraat 88D

    • Leiden, ZH

      Netherlands

      Rijnsburgerweg 10

    • Meyrin, GE

      Switzerland

      Rue de Veyrot 11

    • Daresbury, England

      United Kingdom

      Keckwick Ln

    Advanced Oncotherapy Financials

    Summary Financials

    Net income (H1, 2022)
    (£15.9M)
    Cash (H1, 2022)
    £2.5M
    EBIT (H1, 2022)
    (£12.6M)

    Footer menu